Savings Alert: We've added new, lower prices at most pharmacies for this prescription. Learn More
The GoodRx Pharmacist - December 13, 2016
As 2016 comes to a close, we have some news in the world of diabetes medications! The FDA has recently released Soliqua 100/33, a combination medication for the treatment of type 2 diabetes.
Type 2 diabetes can be very tricky and hard to control. Therefore, the discovery and approval of these new oral and injectable medications are important for healthcare providers and their patients.
What is Soliqua 100/33 indicated for?
Soliqua 100/33 is prescribed to improve glycemic control in adults with type 2 diabetes, in conjunction with diet and exercise. See More
Elizabeth Davis - August 17, 2016
Americans, get ready for sticker shock at the pharmacy.
In 2017, the nation’s largest insurance companies will likely exclude up to 154 different drugs from coverage. If you’re taking one of these prescriptions, your co-pay is about to go way, way up.
Last year, popular drugs including Viagra and Qsymia were dropped by major insurance plans for 2016. The trend continues this year. Almost 50 popular brand-name and generic drugs will likely no longer be covered by one of the nation’s largest prescription insurance providers. See More
Dr. Sharon Orrange - June 07, 2016
Insulin: legal, widely used, and transforms lives. But there are risks—soon you’ll see why we try to spare our type II diabetics from having to start insulin. Using oral medications to their maximum dose and incorporating diet and lifestyle changes is the way to go before resorting to insulin.
Of course, tight blood sugar control is the goal for reducing diabetes related complications (kidney disease, eye disease, neuropathy) but insulin remains one of the most challenging aspects of diabetes management given the risks. See More
Dr. Sharon Orrange - March 03, 2016
Comparing long-acting insulins? Newly approved Tresiba may come out ahead. With the exception of NPH insulin (the original long-acting insulin—examples include Humulin N and Novolin N), they are all going to cost you. So, if you are already paying big bucks for your long-acting insulin, here are some things to think about:
What does a long-acting or basal insulin do for me? This is your baseline insulin, the insulin that is secreted to control your sugars when you are not eating (in the fasting state). See More
The GoodRx Pharmacist - February 17, 2016
Basaglar (insulin glargine) is the newest brand of long-acting insulin to hit the market. It shares its active ingredient (insulin glargine) with Lantus, but is not a generic equivalent and the two can’t be substituted for each other.
Long-acting insulin like Basaglar (also sometimes referred to as basal insulin) are used to keep blood glucose levels stable throughout the day.
Elizabeth Davis - November 23, 2015
You can now find and compare diabetes supplies on GoodRx! Do a search now to see prices for glucose test strips and meters, control solution, syringes and lancets, and more.
As you may already know, shopping around online will typically get you a lower price than what you’ll find walking in to your local pharmacy.
The GoodRx Pharmacist - October 23, 2015
The other recent insulin approvals are what I like to call spin-off insulin products. For example, Toujeo has the same type of insulin as Lantus (insulin glargine), but is more concentrated. Humalog U-200 is the same exact product as Humalog U-100 (insulin lispro), but once again, more concentrated. See More
Dr. Sharon Orrange - October 06, 2015
More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.
Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More
The GoodRx Pharmacist - August 18, 2015
Early in 2015 the FDA approved the first concentrated long-acting insulin known as Toujeo (insulin glargine), and it’s now available in pharmacies.
While Toujeo is the first of its kind, the key word is “concentrated.” It actually contains the same active ingredient (insulin glargine) as Lantus—which is currently the #1 prescribed insulin in the US.
The GoodRx Pharmacist - May 05, 2015
Did you read our blog on insulin vials and think to yourself, does this apply to my insulin pens too? If so, this post is for you!
With so many different insulin and insulin-like products out there these days it can be hard keep track of how long each of these pens stays good.
Depending on your dose, you may still have insulin left in your pen at the manufacturer-recommended time to throw it away. If this sounds like a familiar situation, know that it is important to throw away your pen regardless of whether you have any leftover. See More